Market Tracker

01/17 4:45pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

8.80
Delayed Data
As of Jan 17
 -0.16 / -1.79%
Today’s Change
3.61
Today|||52-Week Range
9.78
+1.85%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close8.96
Today’s open8.85
Day’s range8.61 - 8.90
Volume802,901
Average volume (3 months)1,224,392
Market cap$627.7M
Dividend yield--
Data as of 4:00pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)-1,033.33%
Earnings growth (this year)+112.86%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-80.45%
P/E ratio55.0
Price/Sales49.26
Price/Book6.93

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...-0.80-5.61%
RVNCRevance Therapeutics...-1.40-6.39%
GBTGlobal Blood Therape...-0.30-1.80%
CLLSCellectis SA-0.46-2.51%
Data as of 4:00pm ET, 01/17/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$8.7M
Annual profit (last year)-$39.1M
Net profit margin-450.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
Vice President-
Operations
Meryl J. Longval
Corporate headquarters
Tarrytown, New York

Forecasts